Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

FBI Talk on International Travel

Monday, February 9, 2015
12 pm - 1 pm
Toepfer Room, Adelbert Hall


Are you a researcher who travels abroad to attend scientific or academic conferences? To meet with potential sponsors, donors, or collaborators? To teach at a foreign university or travel with students on an international trip?

Join FBI representatives who will present cutting-edge information on travel concerns for university faculty and employees traveling abroad.

There is no pre-registration. Seating is limited and is first come, first seated.

For more information, contact Lisa Palazzo, Director of Export Control and Privacy Management, at 216.368.5791 or lisa.palazzo@case.edu, or Boyd Kumher, University Chief Compliance, Export Control and Privacy Officer, at 216.368.0833 or boyd.kumher@case.edu.

 
National Multiple Sclerosis Society

The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality.

The prize is administered by the National Multiple Sclerosis Society. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research

For more information and guidelines , visit the Society’s website.

 
NEW Limited Submission: American Diabetes Association Pathway to Stop Diabetes

Key Deadlines: March 2, 2015, 5:00pm (CWRU Internal Submission Deadline), July 1, 2015, 8:00pm EST.

To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association has launched a bold initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, treatment and cures.

Pathway will support creative scientists early in their diabetes research careers, or investigators who are established in other disciplines but would like to expand their focus to diabetes research. Through awards of $1.625 million over the course of up to seven years, the program will provide researchers the freedom, autonomy, time and focus needed to explore new ideas.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
PI Toolkit: How to Find and Interpret Sponsored Project Financial Statements

Friday, February 6, 2015
8:30 am – 9:30 am
Toepfer Room, Adelbert Hall

Thursday, March 5, 2015
11:30 am – 12:30 pm
Wolstein Research Building, Room 1403


This session was created for faculty principal investigators who have active Sponsored Projects. Attendees will learn about financial statements that are available to them via Launchpad. We will be discussing key statements which should be reviewed on a monthly basis to ensure financial transactions occur in accordance with university and sponsor policies. Examples of reports that will be reviewed include Income and Expense Statements, Salary Analysis and Status of Funded Projects.

Registration is online at: http://research.case.edu/Education/Onlinecalendar.cfm.

 
NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)

The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC) Announces the Request for Applications (RFA) for the third funding cycle.

Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. NCAI-CC is seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders). Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.

Eligibility: Investigators from the Cleveland Clinic, Case Western Reserve University, The Ohio State University,Cincinnati Children’s Hospital, and University of Cincinnati

Letter of Intent Deadline: February 10, 2015

For more information visit the NCAI-CC website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.